Why 30 to 40 Percent of Transferred Fat Disappears After a BBL, and What Actually Determines Graft Survival

Ask any experienced surgeon what happens to fat after a Brazilian Butt Lift and you will hear a version of the same number: expect roughly 60 to 70 percent of the grafted volume to survive long term, with the rest reabsorbed by the body in the first three to six months. Patients often interpret this as a failure of technique. It is not. It is the predictable outcome of asking living tissue to survive being removed, processed, and reinjected without a blood supply. Understanding the mechanism helps set realistic expectations and explains why certain practices matter and others are mostly marketing.

Fat is a living graft, not a filler. Each parcel of injected fat contains adipocytes, stem-like stromal cells, connective tissue, and fluid. Unlike hyaluronic acid filler, which is inert, fat must reconnect to the circulatory system to persist. For the first 48 to 72 hours after transfer, grafted fat survives by a process called plasmatic imbibition, essentially soaking up oxygen and nutrients from surrounding tissue fluid like a sponge. This only works over very short distances, generally under two millimeters from a capillary. Fat injected in thick clumps develops a starving core, and that core dies.

Next comes inosculation, where tiny blood vessels in the recipient tissue link up with vessel remnants inside the graft, typically over days three to seven. Finally, true revascularization occurs as new capillaries grow into the graft over the following weeks. Only fat that completes this journey becomes permanent tissue that gains and loses volume with your weight, like fat anywhere else on your body.

Where the lost volume goes. Adipocytes that fail to revascularize undergo necrosis. The body clears the debris through inflammation and macrophage activity, which is one reason early postoperative swelling can make results look dramatically fuller than the final outcome. Some dying fat is partially rescued: preadipocytes and stromal cells are more hypoxia-tolerant than mature fat cells and can regenerate new adipocytes in the graft site, a process sometimes called graft replacement. Occasionally, larger pockets of dead fat wall off into oil cysts or areas of fat necrosis, which can feel firm and may show up on imaging years later. Small areas are common and usually harmless; larger ones can sometimes be aspirated.

Variables with real mechanistic support. A few factors consistently track with better graft survival in the surgical literature. First, injection technique: depositing fat in thin ribbons across many passes and multiple tissue planes maximizes the surface area touching vascularized tissue. This is the single most important controllable variable, and it is also why safe modern practice, which keeps injection in the subcutaneous plane rather than in or under the gluteal muscle, has not meaningfully worsened retention. Subcutaneous fat is a well-vascularized recipient bed. Second, atraumatic harvest and processing: lower suction pressures and gentler handling preserve more viable adipocytes. Centrifugation, washing, and gravity separation all have advocates; head-to-head data show smaller differences between processing methods than between injection techniques. Third, recipient site capacity: skin and soft tissue can only accommodate so much added volume before interstitial pressure rises and chokes off perfusion. Overfilling in one session is counterproductive, which is why very large desired changes are sometimes staged.

Variables with weaker or overstated evidence. Compression garments, special pillows, and strict no-sitting protocols are widely recommended, and avoiding sustained direct pressure on the graft during the imbibition and inosculation window is mechanistically sensible. But the popular claim that a single episode of sitting will kill the result is not supported by strong data, and protocols vary widely between surgeons, from a few days to several weeks of modified sitting. Similarly, supplements marketed to boost fat take have no credible mechanism or trial support. Smoking and nicotine, on the other hand, do have a clear mechanism: vasoconstriction and impaired capillary growth directly undermine the revascularization the graft depends on. Nicotine cessation before and after surgery is one of the few patient-side factors with real biological weight.

What this means for expectations. A competent surgeon plans around resorption, often slightly overfilling within safe limits, and counsels that the result seen at week two is not the result at month six. Volume typically stabilizes between three and six months, once swelling resolves and non-surviving fat has been cleared. Significant weight loss after that point will shrink the grafted fat along with the rest of your body fat, because surviving graft is simply your fat living in a new location.

The takeaway: resorption is not a defect to be eliminated but a boundary condition to be managed. Patients evaluating surgeons should be wary of anyone promising near-total graft survival, and reassured by anyone who explains, unprompted, why some loss is built into the biology.

Related reading: Why Up to Half of Transferred Fat Does Not Survive a BBL, and What Actually Determines Graft Take.